tiprankstipranks
STELLA PHARMA CORPORATION (JP:4888)
:4888
Japanese Market

STELLA PHARMA CORPORATION (4888) Income Statement

0 Followers

STELLA PHARMA CORPORATION Income Statement

Last quarter (Q1 2025), STELLA PHARMA CORPORATION's total revenue was ¥92.40M, an increase of 50.00% from the same quarter last year. In Q1, STELLA PHARMA CORPORATION's net income was ¥-156.68M. See STELLA PHARMA CORPORATION’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 961.06M¥ 269.49M¥ 229.07M¥ 100.10M¥ 205.97M
Gross Profit
¥ 828.72M¥ 203.69M¥ 192.36M¥ 50.73M¥ 165.24M
Operating Expenses
¥ 918.97M¥ 963.99M¥ 999.13M¥ 792.63M¥ 845.81M
Depreciation and Amortization
¥ 34.72M¥ 35.04M¥ 35.05M¥ 34.13M¥ 31.45M
EBITDA
¥ -55.52M¥ -725.26M¥ -771.73M¥ -707.77M¥ -649.12M
Operating Income
¥ -90.25M¥ -760.30M¥ -806.77M¥ -741.90M¥ -680.57M
Other Income/Expenses
¥ -47.62M¥ -676.00K¥ 30.80M¥ -22.18M¥ 24.18M
Pretax Income
¥ -137.87M¥ -760.98M¥ -775.97M¥ -764.09M¥ -656.39M
Net Income
¥ -140.81M¥ -763.75M¥ -778.82M¥ -767.72M¥ -659.24M
Per Share Metrics
Basic EPS
¥ -4.22¥ -24.66¥ -26.97¥ -26.77¥ -23.95
Diluted EPS
¥ -4.22¥ -24.66¥ -26.97¥ -26.77¥ -23.95
Weighted Average Shares Outstanding
33.38M 30.98M 28.88M 28.68M 27.53M
Weighted Average Shares Outstanding (Diluted)
33.38M 30.98M 28.88M 28.68M 27.53M
Currency in JPY

STELLA PHARMA CORPORATION Earnings and Revenue History